Issue of new ordinary shares

RNS Number : 0898N

The MedicX Fund Limited

04 June 2010

 



For Immediate Release                                                                                                        4 June 2010

MedicX Fund Limited

Issue of new ordinary shares

MedicX Fund Limited (the "Company") announces that earlier today it issued for cash 500,000 new ordinary shares of no par value in the Company (the "New Shares").  The issue price per New Share (before expenses) is 72.5 pence.

The net proceeds will be used in further pursuing the investment objectives of the Company.

The New Shares will be admitted to the Official List of the UK Listing Authority and admitted to trading on the London Stock Exchange's main market for listed securities pursuant to the block listing application announced by the Company on 26 June 2008.

Following this issue, the Company has 139,812,243 ordinary shares in issue.

End

For further information, please contact:

MedicX Group                                                                [phone]

Keith Maddin, Chairman

Mike Adams, Managing Director

Mark Osmond, Chief Financial Officer

Collins Stewart Europe Limited                                        [phone]

Andrew Zychowski/Lucy Lewis

Buchanan Communications                                              [phone]

Charles Ryland/George Prassas

MedicX Fund Limited                                                       [phone]

David Staples, Chairman

Information on MedicX Fund Limited

MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 55 properties.

 The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 34 people operating across the UK. 

 The Company's website address is www.medicxfund.com.

Collins Stewart Europe Limited, which is authorised and regulated by the Financial Services Authority, is acting for MedicX Fund Limited and for no one else in connection with the matters detailed in this announcement and will not be responsible to anyone other than MedicX Fund Limited for providing the protections afforded to clients of Collins Stewart Europe Limited or for affording advice in relation hereto, or any other matters referred to herein.

 

END

 

 

IOEZMGGVGDVGGZM